Tatsuki R Kataoka

Summary

Affiliation: Graduate School
Country: Japan

Publications

  1. ncbi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
  2. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
  3. ncbi request reprint CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013
  4. ncbi request reprint An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014

Detail Information

Publications4

  1. ncbi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
    ..Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells...
  2. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
    ..Furthermore, BU40 and rCD100 also downregulated the growth of the HMC1.2 human mast cell line. Thus, targeting CD72 may provide a novel approach to the suppression of mast cell disease such as mastocytosis...
  3. ncbi request reprint CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013
    ..Thus, these results seemed to suggest that CD72 was the therapeutic potential for AML, as is the case of MCTs. ..
  4. ncbi request reprint An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014
    ..Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. ..